Mr. Kevin Wiggins reports

BAUSCH HEALTH TO ANNOUNCE FOURTH-QUARTER AND FULL-YEAR 2023 RESULTS ON FEB. 22

Bausch Health Companies Inc. will release its fourth quarter and full-year 2023 financial results on Thursday, Feb. 22, 2024. Bausch Health will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Bausch Health website prior to the start of the call.

Conference call details

Date:  Thursday, Feb. 22, 2024

Time:  8 a.m. ET

Webcast:  access at the company's website

A replay of the conference call will be available on the company's investor relations website.

To participate in the live question-and-answer (Q&A) session, please register on-line to receive a PIN (personal identification number), which will be sent an hour before the conference call.

About Bausch Health Companies Inc.

Bausch Health Companies is a global diversified pharmaceutical company enriching lives through its relentless drive to deliver better health outcomes. The company develops, manufactures and markets a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through its controlling interest in Bausch + Lomb. The company's ambition is to be a globally integrated health care company, trusted and valued by patients, health care professionals, employees and investors.